215 related articles for article (PubMed ID: 37814223)
1. European Headache Federation (EHF) critical reappraisal and meta-analysis of oral drugs in migraine prevention - part 3: topiramate.
Raffaelli B; García-Azorín D; Boucherie DM; Amin FM; Deligianni CI; Gil-Gouveia R; Kirsh S; Lampl C; Sacco S; Uluduz D; Versijpt J; MaassenVanDenBrink A; Zeraatkar D; Sanchez-Del-Rio M; Reuter U
J Headache Pain; 2023 Oct; 24(1):134. PubMed ID: 37814223
[TBL] [Abstract][Full Text] [Related]
2. European Headache Federation (EHF) critical re-appraisal and meta-analysis of oral drugs in migraine prevention-part 1: amitriptyline.
Lampl C; Versijpt J; Amin FM; Deligianni CI; Gil-Gouveia R; Jassal T; MaassenVanDenBrink A; Ornello R; Paungarttner J; Sanchez-Del-Rio M; Reuter U; Uluduz D; de Vries T; Zeraatkar D; Sacco S
J Headache Pain; 2023 Apr; 24(1):39. PubMed ID: 37038134
[TBL] [Abstract][Full Text] [Related]
3. Antiepileptics other than gabapentin, pregabalin, topiramate, and valproate for the prophylaxis of episodic migraine in adults.
Linde M; Mulleners WM; Chronicle EP; McCrory DC
Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD010608. PubMed ID: 23797674
[TBL] [Abstract][Full Text] [Related]
4. Topiramate for the prophylaxis of episodic migraine in adults.
Linde M; Mulleners WM; Chronicle EP; McCrory DC
Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD010610. PubMed ID: 23797676
[TBL] [Abstract][Full Text] [Related]
5. European Headache Federation (EHF) critical re-appraisal and meta-analysis of oral drugs in migraine prevention-part 2: flunarizine.
Deligianni CI; Sacco S; Ekizoglu E; Uluduz D; Gil-Gouveia R; MaassenVanDenBrink A; Ornello R; Sanchez-Del-Rio M; Reuter U; Versijpt J; de Vries T; Hussain M; Zeraatkar D; Lampl C
J Headache Pain; 2023 Sep; 24(1):128. PubMed ID: 37723437
[TBL] [Abstract][Full Text] [Related]
6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
7. Botulinum toxins for the prevention of migraine in adults.
Herd CP; Tomlinson CL; Rick C; Scotton WJ; Edwards J; Ives N; Clarke CE; Sinclair A
Cochrane Database Syst Rev; 2018 Jun; 6(6):CD011616. PubMed ID: 29939406
[TBL] [Abstract][Full Text] [Related]
8. The comparative effectiveness of migraine preventive drugs: a systematic review and network meta-analysis.
Lampl C; MaassenVanDenBrink A; Deligianni CI; Gil-Gouveia R; Jassal T; Sanchez-Del-Rio M; Reuter U; Uluduz D; Versijpt J; Zeraatkar D; Sacco S
J Headache Pain; 2023 May; 24(1):56. PubMed ID: 37208596
[TBL] [Abstract][Full Text] [Related]
9. Valproate (valproic acid or sodium valproate or a combination of the two) for the prophylaxis of episodic migraine in adults.
Linde M; Mulleners WM; Chronicle EP; McCrory DC
Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD010611. PubMed ID: 23797677
[TBL] [Abstract][Full Text] [Related]
10. Indirect Comparison of Topiramate and Monoclonal Antibodies Against CGRP or Its Receptor for the Prophylaxis of Episodic Migraine: A Systematic Review with Meta-Analysis.
Overeem LH; Raffaelli B; Mecklenburg J; Kelderman T; Neeb L; Reuter U
CNS Drugs; 2021 Aug; 35(8):805-820. PubMed ID: 34272688
[TBL] [Abstract][Full Text] [Related]
11. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.
Diener HC; Bussone G; Van Oene JC; Lahaye M; Schwalen S; Goadsby PJ;
Cephalalgia; 2007 Jul; 27(7):814-23. PubMed ID: 17441971
[TBL] [Abstract][Full Text] [Related]
12. Efficacy, Safety, and Acceptability of Pharmacologic Treatments for Pediatric Migraine Prophylaxis: A Systematic Review and Network Meta-analysis.
Locher C; Kossowsky J; Koechlin H; Lam TL; Barthel J; Berde CB; Gaab J; Schwarzer G; Linde K; Meissner K
JAMA Pediatr; 2020 Apr; 174(4):341-349. PubMed ID: 32040139
[TBL] [Abstract][Full Text] [Related]
13. Acupuncture for the prevention of episodic migraine.
Linde K; Allais G; Brinkhaus B; Fei Y; Mehring M; Vertosick EA; Vickers A; White AR
Cochrane Database Syst Rev; 2016 Jun; 2016(6):CD001218. PubMed ID: 27351677
[TBL] [Abstract][Full Text] [Related]
14. Randomized controlled studies evaluating Topiramate, Botulinum toxin type A, and mABs targeting CGRP in patients with chronic migraine and medication overuse headache: A systematic review and meta-analysis.
Giri S; Tronvik E; Linde M; Pedersen SA; Hagen K
Cephalalgia; 2023 Apr; 43(4):3331024231156922. PubMed ID: 36856015
[TBL] [Abstract][Full Text] [Related]
15. Psychological therapies for the prevention of migraine in adults.
Sharpe L; Dudeney J; Williams ACC; Nicholas M; McPhee I; Baillie A; Welgampola M; McGuire B
Cochrane Database Syst Rev; 2019 Jul; 7(7):CD012295. PubMed ID: 31264211
[TBL] [Abstract][Full Text] [Related]
16. Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.
Weibel S; Rücker G; Eberhart LH; Pace NL; Hartl HM; Jordan OL; Mayer D; Riemer M; Schaefer MS; Raj D; Backhaus I; Helf A; Schlesinger T; Kienbaum P; Kranke P
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD012859. PubMed ID: 33075160
[TBL] [Abstract][Full Text] [Related]
17. Topiramate treatment of chronic migraine: a randomized, placebo-controlled trial of quality of life and other efficacy measures.
Silberstein S; Lipton R; Dodick D; Freitag F; Mathew N; Brandes J; Bigal M; Ascher S; Morein J; Wright P; Greenberg S; Hulihan J
Headache; 2009 Sep; 49(8):1153-62. PubMed ID: 19719543
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.
Silberstein SD; Lipton RB; Dodick DW; Freitag FG; Ramadan N; Mathew N; Brandes JL; Bigal M; Saper J; Ascher S; Jordan DM; Greenberg SJ; Hulihan J;
Headache; 2007 Feb; 47(2):170-80. PubMed ID: 17300356
[TBL] [Abstract][Full Text] [Related]
19. Topiramate in Migraine Prevention: A 2016 Perspective.
Silberstein SD
Headache; 2017 Jan; 57(1):165-178. PubMed ID: 27902848
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
